Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Pediatr. 2007 Jan;150(1):83-8.

Bone mineral density in children and adolescents with neurofibromatosis type 1.

Author information

  • 1Department of Pediatrics, University of Utah, Salt Lake City, Utah 84132, USA. david.stevenson@hsc.utah.edu

Abstract

OBJECTIVE:

To assess whether children and adolescents with neurofibromatosis type 1 (NF1) have decreased bone mineral density (BMD).

STUDY DESIGN:

Bone densitometry of the whole body, hip, and lumbar spine was used in a case-to-control design (84 individuals with NF1: 293 healthy individuals without NF1). Subjects were 5 to 18 years old. Subjects with NF1 were compared with control subjects by using an analysis-of-covariance with a fixed set of covariates (age, weight, height, Tanner stage, and sex).

RESULTS:

Subjects with NF1 had decreased areal BMD (aBMD) of the hip (P <.0001), femoral neck (P <.0001), lumbar spine (P = .0025), and whole body subtotal (P <.0001). When subjects with NF1 were separated in groups with and without a skeletal abnormality, those who did not have a skeletal abnormality still had statistically significant decreases in aBMD compared with control subjects (P <.0001 for whole body subtotal aBMD), although they were less pronounced than in those with osseous abnormalities.

CONCLUSIONS:

These data suggest that individuals with NF1 have a unique generalized skeletal dysplasia, predisposing them to localized osseous defects. Dual energy x-ray absorptiometry may prove useful in identifying individuals with NF1 who are at risk for clinical osseous complications and monitoring therapeutic trials.

PMID:
17188620
[PubMed - indexed for MEDLINE]
PMCID:
PMC1808316
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk